ESSEN SUPPLEMENTS | VIVO BIO TECH | ESSEN SUPPLEMENTS/ VIVO BIO TECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -183.1 | 36.6 | - | View Chart |
P/BV | x | 0.9 | 1.1 | 75.9% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ESSEN SUPPLEMENTS Mar-21 |
VIVO BIO TECH Mar-21 |
ESSEN SUPPLEMENTS/ VIVO BIO TECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 18 | 71 | 25.8% | |
Low | Rs | 5 | 18 | 28.4% | |
Sales per share (Unadj.) | Rs | 0 | 38.6 | 0.0% | |
Earnings per share (Unadj.) | Rs | 0.6 | 4.2 | 13.8% | |
Cash flow per share (Unadj.) | Rs | 0.6 | 8.4 | 7.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 20.3 | 30.6 | 66.4% | |
Shares outstanding (eoy) | m | 9.81 | 13.42 | 73.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 1.2 | - | |
Avg P/E ratio | x | 20.0 | 10.5 | 190.8% | |
P/CF ratio (eoy) | x | 20.0 | 5.3 | 378.7% | |
Price / Book Value ratio | x | 0.6 | 1.5 | 39.6% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 115 | 597 | 19.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 86 | 0.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 518 | 0.0% | |
Other income | Rs m | 24 | 1 | 2,372.5% | |
Total revenues | Rs m | 24 | 519 | 4.7% | |
Gross profit | Rs m | -18 | 178 | -10.4% | |
Depreciation | Rs m | 0 | 56 | 0.0% | |
Interest | Rs m | 0 | 37 | 0.0% | |
Profit before tax | Rs m | 6 | 86 | 6.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 29 | 0.0% | |
Profit after tax | Rs m | 6 | 57 | 10.1% | |
Gross profit margin | % | 0 | 34.3 | - | |
Effective tax rate | % | 0 | 34.1 | -0.1% | |
Net profit margin | % | 0 | 11.0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 39 | 271 | 14.6% | |
Current liabilities | Rs m | 38 | 218 | 17.4% | |
Net working cap to sales | % | 0 | 10.1 | - | |
Current ratio | x | 1.0 | 1.2 | 83.9% | |
Inventory Days | Days | 0 | 0 | - | |
Debtors Days | Days | 0 | 51,413,598 | - | |
Net fixed assets | Rs m | 198 | 524 | 37.8% | |
Share capital | Rs m | 98 | 134 | 73.1% | |
"Free" reserves | Rs m | 102 | 277 | 36.7% | |
Net worth | Rs m | 200 | 411 | 48.6% | |
Long term debt | Rs m | 0 | 147 | 0.0% | |
Total assets | Rs m | 238 | 795 | 29.9% | |
Interest coverage | x | 0 | 3.3 | - | |
Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
Sales to assets ratio | x | 0 | 0.7 | 0.0% | |
Return on assets | % | 2.4 | 11.8 | 20.5% | |
Return on equity | % | 2.9 | 13.8 | 20.8% | |
Return on capital | % | 2.9 | 22.1 | 13.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 19 | 0.0% | |
Fx outflow | Rs m | 0 | 42 | 0.0% | |
Net fx | Rs m | 0 | -23 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -23 | 142 | -16.4% | |
From Investments | Rs m | 27 | -228 | -11.7% | |
From Financial Activity | Rs m | -3 | 88 | -3.9% | |
Net Cashflow | Rs m | 0 | 1 | 9.5% |
Indian Promoters | % | 74.6 | 42.2 | 177.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.1 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 25.4 | 57.8 | 43.9% | |
Shareholders | 968 | 12,632 | 7.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ESSEN SUPPLEMENTS With: VA TECH WABAG
It was a volatile trading session for Indian share markets today. After opening the day on a negative note, Indian share markets extended losses during the first half.